<ul>
 <li>Clinical safety and efficacy</li>
 <li>Initiation and titration</li>
  <li>Administration considerations</li>
  <li>Individualizing treatment</li>
</ul>

Clinical safety and efficacy Initiation and titration Administration considerations Individualizing treatment

Optimizing Triheptanoin Therapy

Patients with long-chain fatty oxidation disorders (LC-FAODs) have historically been treated with diet modification and even-carbon medium-chain triglyceride (MCT) supplementation. In this 45-minute, case-based, modular activity, Sandra van Calcar, PhD, RD, LD, and Jerry Vockley, MD, PhD, address key topics, including disease presentation, historical treatment, emerging treatment with triheptanoin, and nutritional planning specific to patients with LC-FAODs.

Share Optimizing Triheptanoin Therapy

Sign up to save your podcasts

Optimizing Triheptanoin Therapy

Optimizing Triheptanoin Therapy